Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.
about
Helping patients to reduce tobacco consumption in oncology: a narrative reviewFactors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysisCigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial.How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening TrialRisk-benefit profiles of women using tamoxifen for chemoprevention.Accuracy of self-reported tobacco use in newly diagnosed cancer patients.Acceptance and adherence to chemoprevention among women at increased risk of breast cancerCancer survival in New South Wales, Australia: socioeconomic disparities remain despite overall improvements.How do we safely get people to stop smoking?Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical TrialsDoes alcohol consumption modify the risk of endometrial cancer? A dose-response meta-analysis of prospective studies.Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1.Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer.Nicotine and lung cancer.Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer.Tamoxifen vs Raloxifene vs Exemestane for ChemopreventionIntegrating knowledge across domains to advance the science of health behavior: overcoming challenges and facilitating success.Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement.Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death.Impact of Fertility Concerns on Tamoxifen Initiation and Persistence.Reducing tobacco-related cancer incidence and mortality: summary of an institute of medicine workshop.Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor?Chemoprevention of breast cancer
P2860
Q26738416-B9377F0B-6E9E-4461-A5A9-4A1E84CE8F1FQ26773464-E68B70CB-B7F7-4CFA-B66E-D267165EAE31Q33573832-48CBA73C-DB39-43C0-ABCA-8B39045D3828Q33767120-74CAF6E1-CBA8-4B14-A270-63B62BE8672DQ34039907-08BAB8D5-909D-48B0-87B3-5802925FD22FQ34205095-0A7C0736-4AE4-4B55-87EA-CE2986CD2043Q34974865-227F17A6-4703-41DA-A6B5-8FA3A0952363Q35770231-95DAE3EA-BC76-42DC-BC4E-7631650DCCF0Q35854935-6F729F1E-3775-4415-AE35-E0312FBD4033Q35910958-766BE15C-C15B-4746-95E4-02437BF3CD25Q36023746-0E4FAD90-E4D6-4F27-88A6-EF3B9CF5C073Q36135200-400AD648-4F2B-41B4-A69A-5746E7392789Q36224294-6C1E10FE-0CEE-4C51-BB80-477A4593A4BBQ36363405-8FE4E198-6B0D-4038-955E-CF20234C705DQ36654489-841F726D-26D7-437C-A6AF-AF0573CE40CAQ36754902-4D0479A2-E77F-4E8C-B168-8C661B239F4AQ36788354-E1E24679-0646-4094-8FA5-B38D3DCEDE9EQ37097084-67FC21EC-BCB0-4E51-ACE1-9624C70B2F35Q37702995-F6B85A0A-213A-4703-A06D-A0578719E368Q38409103-A39D1F29-C13E-4DAD-B185-54D911F40520Q38727084-F2B3640C-0BDC-4119-B1D5-D09A5F1C5FD1Q38963992-454158D4-1BBF-4E47-BE05-BFFAF654D8B8Q40606927-8694B57E-89EA-4A14-B376-3D391F22D5EBQ42733830-57A08716-E0C8-41E4-8AA8-C4DC601F9715Q52652540-0048B3E1-413C-4DFB-953F-709FF342D231Q57133081-F9B6059E-D9B0-4D74-AA45-6BAE575AE1E1
P2860
Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cigarette smoking, obesity, ph ...... reast Cancer Prevention Trial.
@ast
Cigarette smoking, obesity, ph ...... reast Cancer Prevention Trial.
@en
type
label
Cigarette smoking, obesity, ph ...... reast Cancer Prevention Trial.
@ast
Cigarette smoking, obesity, ph ...... reast Cancer Prevention Trial.
@en
prefLabel
Cigarette smoking, obesity, ph ...... reast Cancer Prevention Trial.
@ast
Cigarette smoking, obesity, ph ...... reast Cancer Prevention Trial.
@en
P2093
P2860
P1476
Cigarette smoking, obesity, ph ...... reast Cancer Prevention Trial.
@en
P2093
D Lawrence Wickerham
Joseph P Costantino
Nicholas J Christian
Patricia A Ganz
Stephanie R Land
Walter M Cronin
William M P Klein
P2860
P304
P356
10.1158/1940-6207.CAPR-11-0172
P577
2011-08-23T00:00:00Z